As with the enzymatic complex from de novo synthesis, SCD-1 is overexpressed in cancer and regulated by different signaling cascades such as MAPK and AKT or systems such as p53 [26], attracting interest in their inhibition [4,5]. The gene discussed is AKT1; the disease is cancer.